Health

‘Two-tier’ health system denies public patient life-extending cancer drug

Imfinzi – which European Commission approved for treatment of bile duct cancer last year – has yet to be evaluated by NCPE

Imfinzi (durvalumab) was approved by the European Commission for treating bile duct cancer in conjunction with chemotherapy last December